Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banqiao District, New Taipei, 22050, Taiwan
Completed
NCT Number: NCT01271764
The Association of G9a Protein and Outcome of Patients With Endometrial Cancer
Tumor invasion and metastasis are the major causes of cancer-related death. Some studies have found that histone methyltransferases, such as EZH2, specifically affect metastasis in breast, gastric and prostate cancer. The functional roles of other members of the HMT family such as G9a in cancer remain obscure. Therefore, the investigators will investigate whether G9a have a role in recurrence/metastasis of endometrial cancer.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year and older
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- all cases with endometrial cancer underwent staging operation
Exclusion criteria
- nil
Treatment and study plan
No drug
OtherThe role of G9a protein in patients with endometrial cancer
Primary outcomes
-
The role of G9a protein in endometrial cancer
Time frame: overall survial, disease-free survival
We will correlate the G9a protein and outcome of endometrial cancer
Sponsors and collaborators
Lead sponsor
Far Eastern Memorial Hospital
Other
Registry information
Important dates
- Study start
- 2011
- Primary completion
- 2012
- Study completion
- 2012
- First posted
- Jan 7, 2011
- Registry last updated
- Sep 26, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.